Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Cost of Care
Posted inCost of Care
Pain, Fear and Waste: The Costs of Unnecessary Care
We explore cascades of care — how a clinician’s desire to be thorough can snowball into a harmful spiral of unnecessary care.
Posted inCost of Care
Ways to Save in Budget Busting Medicare Part B
Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
Posted inHealth Law
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Posted inCost of Care
State AGs Are Doing Work on Drug Pricing
Erin Fuse Brown writes about a new article highlighting the role of state attorneys general on improving drug price affordability.
Posted inCost of Care
Saving Money on Cancer Care Is Hard
Stacie Dusetzina shares new research on the results of one of the largest efforts ever to improve care and control costs for cancer patients.
Posted inCost of Care
Let’s Make a Deal…on Drug Prices
Democrats are on the brink of passing a historic set of drug price reforms. How will they impact patients, insurers and the drug industry?
Posted inInsurance
Has Medicaid Managed Care Delivered On Its Promise?
Letting private insurers offer Medicaid coverage was supposed to lower costs and improve care. Did it work?
Posted inHealth Law
What You Need to Know About the New Surprise Bill Rule
Katie Keith breaks down the newest rule outlining how new federal surprise bill legislation will be enforced.
Posted inCost of Care
Price Hikes Fuel Rising Employer Health Costs
Aditi Sen shares new data from the Health Care Cost Institute on health care spending, utilization and average price trends in the employer-sponsored insurance market.